Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Christoforidis

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Mediators of Inflammation|September 19, 2012
Intravitreal devices for the treatment of vitreous inflammationJohn B Christoforidis, Susie Chang, Angela Jiang, et al.
Journal of Ophthalmology|October 2, 2015
The Vitreomacular Interface in Diabetic RetinopathyDaniel Agarwal, Rachel Gelman, Claudia Prospero Ponce, et al.
Mediators of Inflammation|October 3, 2012
Systemic treatment of vitreous inflammationJohn B Christoforidis, Susie Chang, Angela Jiang, et al.
Retinal Cases & Brief Reports|November 13, 2014
Histology of retina overlying bacterial subretinal abscess and implications for treatmentJohn B Christoforidis, Scott M Warden, Gault M Farrell, et al.
Current Drug Targets|October 5, 2010
Age related macular degeneration and visual disabilityJohn B Christoforidis, Nicola Tecce, Roberto Dell'Omo, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 22, 2016
Epiretinal membrane: optical coherence tomography-based diagnosis and classificationWilliam Stevenson, Claudia M Prospero Ponce, Daniel R Agarwal, et al.
AJNR. American Journal of Neuroradiology|October 17, 2003
CT characteristics of intraocular perfluoro-N-octaneJohn B Christoforidis, Paul A Caruso, Hugh D Curtin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 7, 2016
Ocriplasmin: who is the best candidate?Claudia M Prospero Ponce, William Stevenson, Rachel Gelman, et al.
Current Eye Research|September 21, 2012
Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CTJohn B Christoforidis, Michelle M Williams, Shankaran Kothandaraman, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 5, 2013
The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healingJohn B Christoforidis, Jillian Wang, Angela Jiang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Mediators of Inflammation|September 19, 2012
Intravitreal devices for the treatment of vitreous inflammationJohn B Christoforidis, Susie Chang, Angela Jiang, et al.
Journal of Ophthalmology|October 2, 2015
The Vitreomacular Interface in Diabetic RetinopathyDaniel Agarwal, Rachel Gelman, Claudia Prospero Ponce, et al.
Mediators of Inflammation|October 3, 2012
Systemic treatment of vitreous inflammationJohn B Christoforidis, Susie Chang, Angela Jiang, et al.
Retinal Cases & Brief Reports|November 13, 2014
Histology of retina overlying bacterial subretinal abscess and implications for treatmentJohn B Christoforidis, Scott M Warden, Gault M Farrell, et al.
Current Drug Targets|October 5, 2010
Age related macular degeneration and visual disabilityJohn B Christoforidis, Nicola Tecce, Roberto Dell'Omo, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 22, 2016
Epiretinal membrane: optical coherence tomography-based diagnosis and classificationWilliam Stevenson, Claudia M Prospero Ponce, Daniel R Agarwal, et al.
AJNR. American Journal of Neuroradiology|October 17, 2003
CT characteristics of intraocular perfluoro-N-octaneJohn B Christoforidis, Paul A Caruso, Hugh D Curtin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 7, 2016
Ocriplasmin: who is the best candidate?Claudia M Prospero Ponce, William Stevenson, Rachel Gelman, et al.
Current Eye Research|September 21, 2012
Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CTJohn B Christoforidis, Michelle M Williams, Shankaran Kothandaraman, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 5, 2013
The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healingJohn B Christoforidis, Jillian Wang, Angela Jiang, et al.
Pageof 3